Related Experiment Video
Updated: May 30, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
Cell-based therapy of diabetes: what are the new sources of beta cells?
A Soggia1, E Hoarau, C Bechetoille
1Inserm U845, Research Center Growth and Signalling, Hôpital Necker, Faculté de Médecine, Université Paris Descartes, 156, rue de Vaugirard, 75015 Paris, France.
Abstract:
Diabetes affects 246 million people around the world. To date, no definitive cure has been discovered. Recent clinical trials have shed light on the possibility of successfully transplanting adult pancreatic islets into type 1 diabetic recipients. However, despite encouraging efforts to improve such protocols, the poor availability of pancreatic islets remains a limiting parameter for these transplantation programmes. In the present review, different strategies to obtain other sources of islet beta cells are discussed.
Related Concept Videos
Tissue Renewal without Stem Cells
However, failure of such a system...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Type I Diabetes II: Pathophysiology
iPS Cell Differentiation
Stem Cell Culture
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...